Identification of CHRNA5 rare variants in African-American heavy smokers.
- Authors
- Doyle, Glenn A; Chou, Andrew D; Saung, Wint Thu; Lai, Alison T; Lohoff, Falk W; Berrettini, Wade H
- Year
- 2014
- Journal
- Psychiatric genetics
- PMID
- 24682045
- DOI
- 10.1097/YPG.0000000000000029
- PMCID
- PMC4015337
BACKGROUND: The common CHRNA5 mis-sense coding single-nucleotide polymorphism (SNP) rs16969968:G>A (D398N) has repeatedly been shown to confer risk for heavy smoking in individuals who carry the 'A' allele (encoding the 398N amino acid). The mis-sense SNP has a minor allele frequency of ∼40% in European-Americans, but only ∼7% in African-Americans (http://www.ncbi.nlm.nih.gov/projects/SNP/). We reasoned that there might be other mis-sense variants among African-Americans that could confer the heavy smoking phenotype (defined here as ≥20 cigarettes per day), perhaps in a manner similar to that of the D398N polymorphism in Europeans. MATERIALS AND METHODS: As such, we resequenced 250 African-American heavy smokers, most of whom were homozygous 'G' at rs16969968:G>A (minor allele frequency of 9.6% within the population). RESULTS: Although many novel coding SNPs were not observed, we report an interesting, although rare (perhaps personal), variant in CHRNA5 that could result in nonsense-mediated decay of the aberrant transcript. CONCLUSION: We conclude that, in African-Americans, variants (common or rare) in genes other than CHRNA5 most likely contribute toward the nicotine-dependent phenotype, either independently or in combination with variants in CHRNA5. The functional significance, on CHRNA5 expression or protein function, of the variants found here should be determined in future studies.
African-American individual with a 5 bp deletion in CHRNA5 exon 2(A) The original sequence trace of African-American individual with the 5 bp (1 and 2/3 codon) deletion is shown. (B) The theoretical translation of the mutant allele of CHRNA5 is shown. The ‘AAAAT’ deletion mutation causes a frame-shift leading to stop codons (indicated by stars) in exons 3 and 4 of the spliced transcript. Thus, it is possible the aberrant transcript undergoes non-sense mediated decay (NMD). This frame-shift deletion variant was also found in the NHLBI_ESP. We have submitted the variant to dbSNP.
Haplotype and Linkage Disequilibrium Structure of Variants in CHRNA5 of African-American Heavy SmokersThe linkage disequilibrium (LD) and haplotype block structures containing the indicated SNPs are shown. Analysis was done using Haploview 4.2 (Barrett et al., 2005) using a solid spine of LD. The color scheme of the LD plot is for r2 whereby white indicates r2=0 and black indicates r2=1. Numbers within the shaded squares are those for D′. Haplotypes with frequencies (indicated to the right of the haplotypes) of less than 1% in the population are not shown (see Supplemental Figure S1 for all other haplotypes). Unless otherwise indicated, SNPs are coded in the traditional manner whereby A=1, C=2, G=3 and T=4. An “R” above a SNP number indicates that it is a “rare” variant which may appear monomorphic, but see Supplemental Figure S1. Values for rs2036527:G>A (SNP #1) are not included in the haplotypes as it resides in a different block than the other SNPs examined. Values for rs3841324:GGGCGGGGCCAGAGGGAAATAG>- (SNP #2), which is a 22 bp deletion in the CHRNA5 promoter (Buckland et al., 2005), have been set to “1” for “normal” or “2” for “deletion”. SNP #8 (rs201277469) is coded such that “no insertion”=1 and “T-insertion”=4. SNP #9 (Novel InDel (intron 1)) is coded such that “TC”=1 and “deletion of TC”=2. The 5 bp deletion variant in CHRNA5 exon 2 (SNP #13, coded “1” for “no deletion” and “2” for “deletion”) falls within a rare haplotype (f=0.003) containing the normal promoter (SNP #2) that is not shown in Figure 2, but see Supplemental Figure S1. SNP #15 (Novel InDel (intron 2)) is coded such that “CCTTCTA”=1 and “deletion of CCTTCTA”=2. SNP #31 (Novel InDel (intron 5)) is coded such that “C”=2 and “deletion of C”=1. The asterisks above the markers (SNP #2 and SNP #10) or to the right of the haplotype (f=0.177) indicate that the marker or haplotype showed a nominal trend (p<0.1) toward statistical significance in our exploratory analysis based on CPD.
| Name | Type |
|---|---|
| 1000 Genomes ASW local | cohort |
| 1kGenome_CEU local | cohort |
| 30 CPD local | phenotype |
| ADNFLE local | phenotype |
| African American | cohort |
| African-American cocaine addicted population local | cohort |
| African-American Collaborative Genetic Study of Nicotine Dependence local | cohort |
| African-American GWAS local | cohort |
| African-American heavy smoker local | cohort |
| African-American heavy smoker population local | cohort |
| African-American heavy smokers local | cohort |
| African-American opiate addicted population local | cohort |
| African-American population local | cohort |
| African-Americans | cohort |
| Asian | cohort |
| ASW | cohort |
| Autonomic traits local | phenotype |
| Caucasian-American local | cohort |
| CEU+TSI local | cohort |
| CHB+JPT | drug |
| Chrna3 | gene |
| CHRNA5 | gene |
| CHRNA5-A3-B4 gene cluster local | gene |
| CHRNA5_exon2_5bp_deletion local | variant |
| CHRNA5 exon 2 deletion local | variant |
| CHRNA5 exon 2 frame-shift local | variant |
| CHRNA5 frameshift mutation local | variant |
| CHRNA5 intronic variants local | variant |
| CHRNA5 rare frame-shift variant local | variant |
| Chrna6 | gene |
| Chrnb3 | gene |
| Chrnb4 | gene |
| cigarettes | phenotype |
| cocaine | phenotype |
| CPD phenotype local | phenotype |
| CYP2A6 | gene |
| European ancestry | cohort |
| European cohort (Berrettini et al., 2008) local | cohort |
| European population | cohort |
| Europeans | cohort |
| exon 2 deletion local | variant |
| F266I local | variant |
| Fagerström Test for Nicotine Dependence | phenotype |
| G31G local | variant |
| Haplotype_f0.177 local | variant |
| Haploview 4.2 local | drug |
| HapMap | cohort |
| heavy drinking | phenotype |
| heavy smoker population local | cohort |
| heavy smoking | phenotype |
| heterozygous Chrna5 mutant mice local | cohort |
| higher CHRNA5 mRNA expression local | phenotype |
| higher α5 protein expression local | phenotype |
| K167R local | variant |
| knockout mice | cohort |
| L363Q local | variant |
| maximal CPD smoked local | phenotype |
| MMIHS local | phenotype |
| NHLBI_ESP local | cohort |
| NHLBI ESP African-American local | cohort |
| NHLBI_ESP re-sequencing study local | cohort |
| nicotine | drug |
| nicotine addiction | phenotype |
| nicotine dependence | phenotype |
| nicotine intake levels local | phenotype |
| NIDA Genetics Initiative local | cohort |
| NIMH Genetics Initiative African-American control population local | cohort |
| NIMH/NIDA Genetics Initiative cohort local | cohort |
| non-European ancestry | cohort |
| opiates | drug |
| protective variants in CHRNA3 local | variant |
| protective variants in CHRNB4 local | variant |
| rs12914008:A>G local | variant |
| rs138719535:T>A local | variant |
| rs148722844:G>A local | variant |
| rs16969968 | variant |
| rs2036527 | variant |
| rs2229961:G>A local | variant |
| rs3841324 local | variant |
| rs55781567 local | variant |
| rs55853698 local | variant |
| rs55853698:T>G local | variant |
| rs569207 local | variant |
| rs588765 | variant |
| rs61737499:G>A local | variant |
| rs61740655:C>T local | variant |
| rs76766434:C>T local | variant |
| rs79109919 local | variant |
| rs79109919:T>A local | variant |
| rs79831749:C>T local | variant |
| rs80087508 local | variant |
| rs80087508:A>G local | variant |
| rs8192475:C>T local | variant |
| Rutgers University Cell & DNA Repository | cohort |
| SALS local | phenotype |
| smoking control local | phenotype |
| smoking phenotypes | phenotype |
| smoking status | phenotype |
| SNP | cohort |
| TaqMan assay | drug |
| V134I local | variant |
| wild-type mice | cohort |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Nicotinic Receptor Alpha-5 Subunit Gene Polymorphism is Associated With Heavy Smoking Under a Range of Nicotine Dosing Conditions. | Zuo Y et al. | — | 2024 | → |
| Smoking Progression and Nicotine-Enhanced Reward Sensitivity Predicted by Resting-State Functional Connectivity in Salience and Executive Control Networks. | Gunn MP et al. | — | 2024 | → |
| Deciphering gene contributions and etiologies of somatic mutational signatures of cancer. | Ji X et al. | — | 2023 | → |
| Deciphering of Somatic Mutational Signatures of Cancer | Ji X et al. | — | 2022 | — |
| Polymorphisms of CHRNA3 and CHRNA5: Head and neck cancer and cigarette consumption intensity in a Brazilian population. | Silva MR et al. | — | 2019 | → |
| Human Genetics of Addiction: New Insights and Future Directions. | Hancock DB et al. | — | 2018 | → |
| Genome-wide meta-analysis identifies a novel susceptibility signal at CACNA2D3 for nicotine dependence. | Yin X et al. | — | 2017 | → |
| Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism. | Wen L et al. | — | 2016 | → |
| Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions. | Yang J et al. | — | 2016 | → |
| Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans. | Olfson E et al. | — | 2016 | → |